The health effects of long-term, low-level exposure to organic solvents have been studied for many years. While the volume of literature is great, definitive conclusions regarding chronic neurobehavioral effects of environmental exposure are premature. Methodological shortcomings in research preclud
The neurotoxicity of industrial solvents: A review of the literature
β Scribed by Dr. Edward L. Baker Jr.; Thomas J. Smith; Dr. Philip J. Landrigan
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 750 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0271-3586
No coin nor oath required. For personal study only.
β¦ Synopsis
Organic solvents, particularly stryrene, are used widely in boatbuilding. They may be absorbed by workers either through the respiratory tract or the skin. Uptake is influenced by level and duration of exposure, work load, and specific physicochemical features of each solvent, as well as by work practices and use of protective equipment. Kinetics of metabolism and excretion kinetics are highly variable among compounds. Metabolites can be measured in blood, urine, or exhaled breath and may serve as indirect indices of absorption.
Acute high-dose exposure to organic solvents can produce a transient narcotic effect on the central nervous system. This effect occurs in proportion to brain dose, which in turn is determined by intensity and duration of exposure. Additionally, chronic exposures to organic solvents have been reported to produce an increased frequency of neurologic signs and symptoms. These findings include peripheral neuropathies and toxic encephalopathies. The latter are characterized by alterations in affect, memory loss, and impaired cognition. Concern exists that prolonged excessive exposure to organic solvents may lead to premature and persistent dementia in certain workers.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Bortezomib is active in heavily pretreated multiple myeloma patients; the doseβlimiting toxicity is peripheral neuropathy (PN). ## METHODS. The authors retrospectively reviewed the incidence, severity, and risk factors for PN in 78 patients who received bortezomib. The
## Abstract Labelling programs seek first to encourage a move towards more environmentally friendly consumption patterns, and second to induce productive structures, governments and other agents to increase the environmental standards of the products and services in the economy. This paper is devot